Francine M Foss

24PUBLICATIONS
142CO-AUTHORS
Tumour immunologyHaematological tumoursPredictive and prognostic markersMolecular targetsNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Mar 14, 2026
Clinical outcomes of mature T- and NK-cell lymphomas in hepatitis B virus positive individuals: results from the PETAL Global Consortium.

Colin J Thomas, Min Jung Koh, Omar Elghawy

|Feb 24, 2026
A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis.

Joseph M Tuscano, Tamer Othman, Paul Frankel

|Dec 05, 2025
Early time to relapse as a survival prognosticator in nodal mature T-cell lymphomas: results from the PETAL consortium.

Mark N Sorial, Luis E Malpica Castillo, Carlos Chiattone

|Nov 10, 2025
A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis.

Joseph M Tuscano, Tamer Othman, Paul Frankel

|Oct 28, 2025
Effect of Valemetostat on the Pharmacokinetics of Midazolam and Digoxin: A Phase 1 Drug-Drug Interaction Study in Patients With Non-Hodgkin Lymphoma.

Masaya Tachibana, Steven Horwitz, Eric Jacobsen

|Sep 19, 2025
Weekly dosing schedule of brentuximab vedotin is well tolerated in mycosis fungoides/Sézary syndrome.

Megan Lee, Molly Schiffer, Iris Isufi

Pageof 4

Frequent Collaborators

5 joint publications

Robert Stuver

4 joint publications

Monica Elena Cabrera

4 joint publications

Henry Miles Prince

4 joint publications

Salvia Jain